Commentary
Article
From newsworthy moments to groundbreaking research, these were the most-read coronavirus-related articles on Pharmacy Times in 2023.
1. Study Finds Comorbidities, Pre-Existing Disease Have Significant Impact On COVID-19 Outcomes
The study also found significant evidence of outcomes disparities between minority populations and White populations. Read More Here.
peterschreiber.media - stock.adobe.com
2. Missed or Delayed Pediatric Preventative Care During COVID-19 Pandemic Influenced By Race, Enabling Factors
The study is among the first to examine delayed or missed pediatric preventative care during COVID-19 and consider determinants, race, and ethnic group, according to the authors. Read More Here.
3. Clinical Overview: 2023-2024 COVID-19 Vaccines
An overview of updated CDC ACIP recommendations for COVID-19 vaccines available through commercial channels for the 2023-2024 season. Read More Here.
4. FDA Authorizes Updated COVID-19 Vaccine Formulations for Current Variants
FDA grants updated Moderna and Pfizer-BioNTech COVID-19 vaccines emergency use authorization to target currently circulating variants of the virus. Read More Here.
5. Clinical Updates On COVID-19 Treatments and Vaccines
Even with the current available treatment options, it is important to recognize the importance of masking, particularly for those with immunocompromised conditions. Read More Here.
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
2 Commerce Drive
Cranbury, NJ 08512